Journal profile
German Journal of Pharmaceuticals and Biomaterials
ISSN 2750-624X · eISSN 2750-6258 · German Journal of Pharmaceuticals and Biomaterials · Germany
German Journal of Pharmaceuticals and Biomaterials: diamond open access (no APC); no APC; review about 10 weeks (community reports); acceptance rate 37% (journal website); 18 articles in 2025.
Scope
Aims, scope and focus
German Journal of Pharmaceuticals and Biomaterials is published by German Journal of Pharmaceuticals and Biomaterials. By OpenAlex counts of its recent articles, its largest topics are Advanced Drug Delivery Systems, Drug Solubulity and Delivery Systems and Medicinal Plant Research, together about 29.7% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
German Journal of Pharmaceuticals and Biomaterials (GJPB) [ p-ISSN: 2750-624X | e-ISSN:2750-6258 ] is an interdisciplinary peer-reviewed open access scientific journal that publishes high-quality experimental and theoretical research that contributes significantly to all aspects of pharmaceutical sciences and biomaterials and their related subjects including their applications in human (covering experimental and clinical therapeutics). The mission is to publish scientific work that has followed laborious methodologies and contribute to progress and development in pharmaceuticals and biomaterials. Scientific areas within the scope of this journal include but are not limited to pharmaceutics (all aspects of formulations and drug delivery systems, including oral, pulmonary, nasal, parenteral and transdermal delivery) and biopharmaceutics, including pharmaceutical biotechnology products, biochemistry and microbiology, pharmacology and toxicology, applied separation science (covers all areas of analytical/chromatography techniques), natural product drug discovery, medicinal chemistry, and bioactive polymers. This journal is also interested in work that addresses biomaterials but is not limited to covering all aspects of biomaterials with a broad range of physical, biological and chemical sciences that support the design of biomaterials and the clinical/scientific disciplines in which they are used. Country of Publication: GermanyFrequency: Quarterly (4 issues/year).
From the journal's Aims & Scope
Editorial board by country: none in mainland China; most named United States 2, Germany 2, United Kingdom 1, Japan 1, India 1 (13 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics12.1%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics8.8%
- Medicinal Plant ResearchAgricultural and Biological Sciences8.8%
- Nanoparticle-Based Drug DeliveryMaterials Science6.6%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics6.6%
- Polysaccharides Composition and ApplicationsAgricultural and Biological Sciences5.5%
- Computational Drug Discovery MethodsComputer Science4.4%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 5OpenAlex ·
- i10-index
- 2OpenAlex ·
- 2-year mean citedness
- 0.79OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher)
- 4Publisher website ·
Articles by year OpenAlex count · 73 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 4 | 4 | 30 |
| 2025 | 18 | 18 | 50 |
| 2024 | 17 | 17 | 35 |
| 2023 | 17 | 17 | 24 |
| 2022 | 17 | 17 | 5 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 10 weeksLetPub ·
- Acceptance rate (publisher)
- 37%Publisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted12
- case reportThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- case studyThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- commentaryThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- editorialThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- letterThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- opinionThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- original articleThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- research articleThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- research reportThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- reviewThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- review articleThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
- short communicationThe Editorial Board considers the following types of paper: Letters, Research Articles, Original Articles, Review Articles (including Mini-reviews and Critical …Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Peer review, Plagiarism
- Authorship Authorship/Author Disclosure
All the authors in a manuscript are equally responsible for the technical information communicated to the journal. Thus, it is necessary that all authors must read and approve the final version of the manuscript before submitting it to the journal. All named authors must have made an active contribution to the conception and design and/or analysis and interpretation of the data and/or the drafting…
Source ↗Publisher website ·- Conflicts of interest Authorship/Author Disclosure
All the authors in a manuscript are equally responsible for the technical information communicated to the journal. Thus, it is necessary that all authors must read and approve the final version of the manuscript before submitting it to the journal. All named authors must have made an active contribution to the conception and design and/or analysis and interpretation of the data and/or the drafting…
Source ↗Publisher website ·- Peer review Peer-Review
Policies designed in compliance with ICMJE and COPE best practice guidelines. Model summary
If a manuscript is successful in making it through the initial check and desk review, it is next sent for double-blind peer review. The article will be evaluated by a minimum of two experts in the relevant subject area, both of whose identities will be kept confidential (double-blind peer-review process). Kindly refer to our policies regarding peer review.
Source ↗Publisher website ·- Plagiarism
Plagiarism check using iThenticate. Model summary
iThenticate (online plagiarism detection software) will be used to perform a plagiarism check on the articles that are submitted.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- German Journal of Pharmaceuticals and Biomaterials
- Country or region
- Germany
- Language
- English
- ISSN
- 2750-624X
- Electronic ISSN
- 2750-6258
- Latest issue on the website
- Volume 4, Issue 4 (2025)
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about German Journal of Pharmaceuticals and Biomaterials
How long does peer review take at German Journal of Pharmaceuticals and Biomaterials?
Authors report an average review time of about 10 weeks; the journal's website gives an acceptance rate of 37%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of German Journal of Pharmaceuticals and Biomaterials?
According to the journal's author guidelines: First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of German Journal of Pharmaceuticals and Biomaterials based?
Of the 13 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (2), Germany (2) and United Kingdom (1). Counted from the institutions listed on the board page; for reference only.
Which databases index German Journal of Pharmaceuticals and Biomaterials?
According to LetPub and DOAJ records, German Journal of Pharmaceuticals and Biomaterials is indexed in DOAJ.
Is German Journal of Pharmaceuticals and Biomaterials open access, and what is the APC?
German Journal of Pharmaceuticals and Biomaterials is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .